How to break through a VO max plateau [1:40:45]
You are not a candidate if you: If you are unsure whether BPC-157 is safe for you, that is exactly what the consultation is for
Ideal candidates for leading with NAD+: Patients over 40 experiencing persistent fatigue that does not resolve with sleep or lifestyle changes Individuals with metabolic syndrome, insulin resistance, or difficulty managing weight despite dietary effort Patients recovering from substance use, where NAD+ IV therapy has shown measurable benefit in reducing withdrawal symptoms and cravings High-performance athletes or executives seeking cognitive edge and faster physical recovery Patients with early neurodegenerative concerns who want evidence-supported mitochondrial support GHK-Cu Dosage and NAD+ Dosage: What Clinical Protocols Actually Use Dosing varies based on delivery route, patient body weight, and clinical goal
The resulting data suggested that ferroptosis may serve a role in the pathogenesis of TNBC
While Matrixyl targets wrinkle reduction and Argireline helps relax facial muscles, GHK-Cu goes beyond cosmetic effects by actively supporting skin regeneration, reducing inflammation, and improving healing
W Drge, R Breitkreutz - Glutathione and immune function - Proc Nutr Soc - 2000 Nov
